Indication
Rheumatic Heart Disease
5 clinical trials
5 products
2 drugs
Clinical trial
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A Non-inferiority Randomized TrialStatus: Recruiting, Estimated PCD: 2027-03-31
Product
Phenoxymethyl PenicillinProduct
Benzathine Penicillin GClinical trial
Effect of Gliflozins on Heart Failure Due to Regurgitant Rheumatic Valve DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
SGLT2 inhibitorClinical trial
A Follow-up Study for Patients Who Participated in the GOAL Trial (GOAL-Post)Status: Active (not recruiting), Estimated PCD: 2024-03-30
Product
Penicillin G BenzathineClinical trial
Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression: A Feasibility Study For A Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2040-02-01
Drug
AtorvastatinDrug
VarlilumabClinical trial
Next Generation Sequencing Approach to the Study of Rheumatic Heart DiseaseStatus: Recruiting, Estimated PCD: 2024-07-01
Product
Next generation sequencing